Brief: Kazia Executes Licensing Agreement With QIMR Berghofer
12/09/2024 13:37
Sept 12 (Reuters) - Kazia Therapeutics Ltd KZIA.O :
* KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER
* KAZIA THERAPEUTICS LTD - RECEIVES EXCLUSIVE WORLDWIDE
LICENSE
FOR PI3K INHIBITOR COMBINATIONS
Source text for Eikon: ID:nPn1gKXbDa
Further company coverage: KZIA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
Kazia drops on $40 mln equity offering to fund breast cancer drug
Kazia slides after breast cancer drug update, equity offering launch
Brief: Kazia Therapeutics Limited Announces Proposed Public Offering